Literature DB >> 2111024

Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals.

T Jehuda-Cohen1, B A Slade, J D Powell, F Villinger, B De, T M Folks, H M McClure, K W Sell, A Ahmed-Ansari.   

Abstract

Identification of human immunodeficiency virus type 1 (HIV-1)-infected individuals is of paramount importance for the control of the spread of AIDS worldwide. Currently, the vast majority of screening centers throughout the world rely on serological techniques. As such, clinically asymptomatic but HIV-infected, seronegative individuals are rarely identified. In this report we show that 18% (30/165) of seronegative individuals who were considered to be a unique cohort of patients at high risk for HIV infection had circulating B cells that, upon in vitro polyclonal activation with pokeweed mitogen, produced antibodies reactive with HIV. Furthermore, polymerase chain reaction analysis of DNA obtained from aliquots of the peripheral blood mononuclear cells from these seronegative but pokeweed mitogen assay-positive individuals tested revealed the presence of HIV-specific sequences in a significant number of samples. In addition, depletion of CD8+ T cells from peripheral blood mononuclear cells of HIV-1-seronegative individuals prior to in vitro culture with pokeweed mitogen resulted in increased sensitivity for detecting HIV-reactive antibodies. This assay has obvious epidemiological implications, especially in the case of high-risk groups, and also provides a simple technique to enhance detection of HIV-infected individuals. Of further interest is the determination of the mechanisms related to the lack of HIV-specific antibodies in the serum of these infected individuals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2111024      PMCID: PMC54026          DOI: 10.1073/pnas.87.10.3972

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies.

Authors:  B Hofmann; B O Lindhardt; J Gerstoft; C S Petersen; P Platz; L P Ryder; N Odum; E Dickmeiss; P B Nielsen; S Ullman
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

2.  Identification of HIV-infected seronegative individuals by a direct diagnostic test based on hybridisation to amplified viral DNA.

Authors:  M Loche; B Mach
Journal:  Lancet       Date:  1988-08-20       Impact factor: 79.321

3.  HIV and HLA similarity.

Authors:  J A Young
Journal:  Nature       Date:  1988-05-19       Impact factor: 49.962

4.  Effect of T3 modulation on pokeweed mitogen-induced T cell activation: evidence for an alternative pathway of T cell activation.

Authors:  J L Ceuppens; L Meurs; M L Baroja; J P Van Wauwe
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

5.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

6.  Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.

Authors:  S Koenig; H E Gendelman; J M Orenstein; M C Dal Canto; G H Pezeshkpour; M Yungbluth; F Janotta; A Aksamit; M A Martin; A S Fauci
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

7.  DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.

Authors:  C Y Ou; S Kwok; S W Mitchell; D H Mack; J J Sninsky; J W Krebs; P Feorino; D Warfield; G Schochetman
Journal:  Science       Date:  1988-01-15       Impact factor: 47.728

8.  B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters.

Authors:  H Mizuma; S Litwin; S Zolla-Pazner
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

9.  Association of human immunodeficiency virus infection and autoimmune phenomena.

Authors:  R G Kopelman; S Zolla-Pazner
Journal:  Am J Med       Date:  1988-01       Impact factor: 4.965

10.  Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.

Authors:  H Golding; F A Robey; F T Gates; W Linder; P R Beining; T Hoffman; B Golding
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  13 in total

1.  Concordance between polymerase chain reaction and antibody detection in the diagnosis of human immunodeficiency virus type 1 infection.

Authors:  L Romano; M Catucci; A De Milito; G Venturi; M Zazzi; P Almi; A Gonnelli; M Rubino; R Maestrini; P E Valensin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

Review 2.  B cell responses to HIV and the development of human monoclonal antibodies.

Authors:  J E Boyd; K James
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Seroprevalence of anti-HTLV I/II and anti-HIV-1 antibodies in a sample population in the Marche Region, Italy.

Authors:  F Mignini; L Quarenghi; S Cipriani; M Bartolucci; I Covelli
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

Review 4.  Mechanisms of resistance to HIV infection.

Authors:  W A Paxton; R A Koup
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA.

Authors:  P V Baskar; G D Collins; B A Dorsey-Cooper; R S Pyle; J E Nagel; D Dwyer; G Dunston; C E Johnson; N Kendig; E Israel; D R Nalin; W H Adler
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

6.  P24 antigen detection, viral isolation, DNA-PCR and in vitro antibody production for the diagnosis of HIV-1 latent infection in heterosexual women at high risk for HIV-1 infection.

Authors:  M Di Stefano; J R Fiore; M Chironna; G Buccoliero; C Romanelli; L La Grasta; M Quarto; G Angarano; G Pastore
Journal:  Genitourin Med       Date:  1995-04

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Development of oligonucleotide primers and probes against structural and regulatory genes of human immunodeficiency virus type 1 (HIV-1) and their use for amplification of HIV-1 provirus by using polymerase chain reaction.

Authors:  M R Dawood; R Allan; K Fowke; J Embree; G W Hammond
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

9.  Detection of human immunodeficiency virus type 1 by PCR before seroconversion in high-risk individuals who remain seronegative for prolonged periods.

Authors:  M T Gorriño; C Campelo; M D Suarez; A Santamaría; C Malave; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

10.  Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.

Authors:  M Girard; M P Kieny; A Pinter; F Barre-Sinoussi; P Nara; H Kolbe; K Kusumi; A Chaput; T Reinhart; E Muchmore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.